Serum potassium is an age-dependent risk factor for pre-diabetes and diabetes in the Israeli population

被引:6
|
作者
Doenyas-Barak, Keren [1 ,2 ]
Beberashvili, Ilia [1 ,2 ]
Vinker, Shlomo [2 ,3 ]
机构
[1] Assaf Harofeh Med Ctr, Div Nephrol, IL-70300 Zerifin, Israel
[2] Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel
[3] Clalit Hlth Serv, Tel Aviv, Israel
来源
DIABETES & VASCULAR DISEASE RESEARCH | 2014年 / 11卷 / 02期
关键词
potassium level; dysglycaemia; pre-diabetes; Type; 2; diabetes; THIAZIDE DIURETICS; MELLITUS; GLUCOSE; ADULTS;
D O I
10.1177/1479164114521227
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: We analysed the association between serum potassium, within the normal range, and early signs of diabetes in an Israeli population. Research design and methods: A computerized database of the Clalit Health Services was used for obtaining information regarding patients' baseline serum potassium levels. The main study outcome was dysglycaemia, defined as fasting glucose > 100 mg/dL, HbA1C > 6.5 gr% (48 mmol/mol) or a new diagnosis of diabetes. A secondary outcome was overt diabetes. Results: Included in the study were 71,597 patients, mean age 40.8 +/- 13.4 years. After a mean follow-up period of 5.3 +/- 2.2 years, dysglycaemia decreased [odds ratio (OR) = 0.95; 95% confidence interval (CI) = 0.906-0.997; p = 0.038], as did the incidence of overt diabetes (OR = 0.86; 95% CI = 0.793-0.934; p = 0.0001), for every 1 mmol/L elevation in serum potassium in the normal range. But analysis of subpopulation reveals that when elevated serum potassium was associated with low adjusted ORs for predicting dysglycaemia (OR = 0.904 with a 95% CI of 0.849-0.963; p = 0.002), the opposite effect was demonstrated over the age of 41 years (OR = 1.113 with a 95% CI of 1.048-1.104; p < 0.001). Conclusions: This study demonstrates age-related association between serum potassium and the risk of dysglycaemia.
引用
收藏
页码:103 / 109
页数:7
相关论文
共 50 条
  • [41] A forgotten population? Investigation of diabetes and pre-diabetes risk in troponin negative chest pain admissions: a pilot study
    Puttanna, A.
    Moritz, G.
    Harvey, S.
    Affarah, L.
    Kumar, A.
    Raskauskiene, D.
    DIABETIC MEDICINE, 2015, 32 : 192 - 192
  • [42] Relationship between serum pro- and anti-inflammatory cytokine and growth factor concentrations with the age and gender adjusted prevalence of diabetes and pre-diabetes
    Elahe Mahdipour
    Maryam Azizian
    Seyed Reza Mirhafez
    Shiva Ganjali
    Sara Shoeibi
    Mohsen Nematy
    Habibollah Esmaily
    Gordon AA Ferns
    Majid Ghayour Mobarhan
    International Journal of Diabetes in Developing Countries, 2017, 37 : 313 - 319
  • [43] Relationship between serum pro- and anti-inflammatory cytokine and growth factor concentrations with the age and gender adjusted prevalence of diabetes and pre-diabetes
    Mahdipour, Elahe
    Azizian, Maryam
    Mirhafez, Seyed Reza
    Ganjali, Shiva
    Shoeibi, Sara
    Nematy, Mohsen
    Esmaily, Habibollah
    Ferns, Gordon A. A.
    Mobarhan, Majid Ghayour
    INTERNATIONAL JOURNAL OF DIABETES IN DEVELOPING COUNTRIES, 2017, 37 (03) : 313 - 319
  • [44] The association of adiponectin with risk of pre-diabetes and diabetes in different subgroups: cluster analysis of a general population in south China
    Gong, Xun
    You, Lili
    Li, Feng
    Chen, Qingyu
    Chen, Chaogang
    Zhang, Xiaoyun
    Zhang, Xiuwei
    Xuan, Wenting
    Sun, Kan
    Lao, Guojuan
    Wang, Chuan
    Li, Yan
    Xu, Mingtong
    Ren, Meng
    Yan, Li
    ENDOCRINE CONNECTIONS, 2021, 10 (11) : 1410 - 1419
  • [45] Serum nesfatin-1 is a biomarker of pre-diabetes and interplays with cardiovascular risk factors
    Ragaa Abdelshaheed Matta
    Sahar Hossam El-Hini
    Ahmed Mohamed Saad Eldin Salama
    Hend Mohamed Moaness
    The Egyptian Journal of Internal Medicine, 2022, 34 (1)
  • [46] Pre-Diabetes Detection and Intervention for High Risk Communities
    Kuk, Jennifer L.
    Davachi, Shahnaz
    Kriska, Andrea M.
    Riddell, Michael C.
    Gregg, Edward W.
    JOURNAL OF PHYSICAL ACTIVITY & HEALTH, 2010, 7 : S327 - S329
  • [47] Measuring Continuous Changes in Individual Cardiovascular Risk for People With Diabetes and Pre-Diabetes
    Sears, Lindsay
    Guerra, Jorge
    Patel, Veena
    Sears, Lindsay
    Goldner, Dan
    Dachis, Jeff
    CIRCULATION, 2021, 144
  • [48] 2 Comparisons of clinical scores of risk of diabetes screening for pre-diabetes, diabetes, metabolic syndrome and cardiovascular risk
    Cosson, E.
    Tchatchouang, E. Hamo
    Nguyen, M. T.
    Ba, H.
    Banu, I.
    Valonsi, P.
    DIABETES & METABOLISM, 2009, 35 : A17 - A17
  • [49] Transition from pre-diabetes to diabetes and predictors of risk in Mexican-Americans
    Wu, Shenghui
    McCormick, Joseph B.
    Curran, Joanne E.
    Fisher-Hoch, Susan P.
    DIABETES METABOLIC SYNDROME AND OBESITY-TARGET & THERAPY, 2017, 10 : 491 - 503
  • [50] Pre-diabetes in overweight youth and early atherogenic risk
    Burns, Stephen F.
    Lee, SoJung
    Bacha, Fida
    Tfayli, Hala
    Hannon, Tamara S.
    Arslanian, Silva A.
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2014, 63 (12): : 1528 - 1535